These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 10688046)

  • 21. Contrasting genotypes of the tau gene in two phenotypically distinct patients with P301L mutation of frontotemporal dementia and parkinsonism linked to chromosome 17.
    Kobayashi T; Mori H; Okuma Y; Dickson DW; Cookson N; Tsuboi Y; Motoi Y; Tanaka R; Miyashita N; Anno M; Narabayashi H; Mizuno Y
    J Neurol; 2002 Jun; 249(6):669-75. PubMed ID: 12111297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and genetic features of families with frontotemporal dementia and parkinsonism linked to chromosome 17 with a P301S tau mutation.
    Baba Y; Baker MC; Le Ber I; Brice A; Maeck L; Kohlhase J; Yasuda M; Stoppe G; Bugiani O; Sperfeld AD; Tsuboi Y; Uitti RJ; Farrer MJ; Ghetti B; Hutton ML; Wszolek ZK
    J Neural Transm (Vienna); 2007 Jul; 114(7):947-50. PubMed ID: 17318302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly.
    Hasegawa M; Smith MJ; Goedert M
    FEBS Lett; 1998 Oct; 437(3):207-10. PubMed ID: 9824291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cathepsin D in a murine model of frontotemporal dementia with Parkinsonism-linked to chromosome 17.
    Fernández-Montoya J; Pérez M
    J Alzheimers Dis; 2015; 45(1):1-14. PubMed ID: 25428250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple signaling factors and drugs alleviate neuronal death induced by expression of human and zebrafish tau proteins in vivo.
    Wu BK; Yuan RY; Lien HW; Hung CC; Hwang PP; Chen RP; Chang CC; Liao YF; Huang CJ
    J Biomed Sci; 2016 Feb; 23():25. PubMed ID: 26852117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CHIP-ping away at tau.
    Goryunov D; Liem RK
    J Clin Invest; 2007 Mar; 117(3):590-2. PubMed ID: 17332887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's disease.
    Goedert M; Spillantini MG
    Biochim Biophys Acta; 2000 Jul; 1502(1):110-21. PubMed ID: 10899436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo analysis of wild-type and FTDP-17 tau transgenic mice.
    Götz J; Barmettler R; Ferrari A; Goedert M; Probst A; Nitsch RM
    Ann N Y Acad Sci; 2000; 920():126-33. PubMed ID: 11193141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperexcitability and epileptic seizures in a model of frontotemporal dementia.
    García-Cabrero AM; Guerrero-López R; Giráldez BG; Llorens-Martín M; Avila J; Serratosa JM; Sánchez MP
    Neurobiol Dis; 2013 Oct; 58():200-8. PubMed ID: 23774255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impairments in impulse control in mice transgenic for the human FTDP-17 tauV337M mutation are exacerbated by age.
    Lambourne SL; Humby T; Isles AR; Emson PC; Spillantini MG; Wilkinson LS
    Hum Mol Genet; 2007 Jul; 16(14):1708-19. PubMed ID: 17517691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of an altered form of tau in Sf9 insect cells results in the assembly of polymers resembling Alzheimer's paired helical filaments.
    Gómez-Ramos A; Abad X; López Fanarraga M; Bhat R; Zabala JC; Avila J
    Brain Res; 2004 May; 1007(1-2):57-64. PubMed ID: 15064135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular genetics of chromosome 17 tauopathies.
    Hutton M
    Ann N Y Acad Sci; 2000; 920():63-73. PubMed ID: 11193178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transgenic mice expressing mutant (N279K) human tau show mutation dependent cognitive deficits without neurofibrillary tangle formation.
    Taniguchi T; Doe N; Matsuyama S; Kitamura Y; Mori H; Saito N; Tanaka C
    FEBS Lett; 2005 Oct; 579(25):5704-12. PubMed ID: 16219306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accelerated filament formation from tau protein with specific FTDP-17 missense mutations.
    Nacharaju P; Lewis J; Easson C; Yen S; Hackett J; Hutton M; Yen SH
    FEBS Lett; 1999 Mar; 447(2-3):195-9. PubMed ID: 10214944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Animal models of tauopathies].
    Higuchi M
    Rinsho Shinkeigaku; 2006 Nov; 46(11):928-30. PubMed ID: 17432223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clioquinol rescues Parkinsonism and dementia phenotypes of the tau knockout mouse.
    Lei P; Ayton S; Appukuttan AT; Volitakis I; Adlard PA; Finkelstein DI; Bush AI
    Neurobiol Dis; 2015 Sep; 81():168-75. PubMed ID: 25796563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical, genetic and pathological aspects of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)].
    Tsuboi Y
    Rinsho Shinkeigaku; 2004 Nov; 44(11):875-8. PubMed ID: 15651319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FTDP-17 tau mutations decrease the susceptibility of tau to calpain I digestion.
    Yen S; Easson C; Nacharaju P; Hutton M; Yen SH
    FEBS Lett; 1999 Nov; 461(1-2):91-5. PubMed ID: 10561502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular and molecular modifier pathways in tauopathies: the big picture from screening invertebrate models.
    Hannan SB; Dräger NM; Rasse TM; Voigt A; Jahn TR
    J Neurochem; 2016 Apr; 137(1):12-25. PubMed ID: 26756400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro polymerization of tau protein monitored by laser light scattering: method and application to the study of FTDP-17 mutants.
    Gamblin TC; King ME; Dawson H; Vitek MP; Kuret J; Berry RW; Binder LI
    Biochemistry; 2000 May; 39(20):6136-44. PubMed ID: 10821687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.